Our animal data suggest that AST-120 treatment prevented uremic toxin-induced attenuation of cardiac microRNAs-29b post-MI, leading to significant downregulation of microRNA-29b target genes TGF-β1, collagen 1A1 and fibronectin-1. This evidence concerns the gene TGFB1 and myocardial infarction.